ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P ASX 200
7,968.20
0.60%
S&P ASX All Technology
3,399.00
0.55%
Brent Oil
65.89
0.18%
US Dollar vs AUD
1.56391
0.09%
Bitcoin
93,345.02
-0.67%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Invivyd Inc (IVVD) Share Price

Invivyd Inc

Invivyd Inc (IVVD)

NASDAQ
0.6684
0.0241
(3.74%)
Closed 25 April 6:00AM
Delayed by 15 minutes
0.6675
-0.0009
(-0.13%)
After Hours: 9:45AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.6675
Bid
0.6674
Offer
1.20
Volume
969,983
0.6145 Day's Range 0.666
0.3546 52 Week Range 2.74
Market Cap
80.074M
Previous Close
0.6443
Open
0.6424
Last Trade
880
@
0.6675
(formt)
Last Trade Time
Financial Volume
US$ 618,311
VWAP
0.637445
Average Volume (3m)
15,973,235
Shares Outstanding
119,961,445
Dividend Yield
-
PE Ratio
-3.28
Earnings Per Share (EPS)
-1.42
Revenue
25.38M
Net Profit
-169.93M

About Invivyd Inc

Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
invivyd.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Invivyd Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IVVD. The last closing price for Invivyd was US$0.64. Over the last year, Invivyd shares have traded in a share price range of US$ 0.3546 to US$ 2.74.

Invivyd currently has 119,961,445 shares in issue. The market capitalisation of Invivyd is US$77.29 million. Invivyd has a price to earnings ratio (PE ratio) of -3.28.

Ask ADVFN Intelligence (AI)

IVVD Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
21 April 2025
IVVD (3.74%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
08 April 2025
IVVD (3.74%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
08 April 2025
IVVD (3.74%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 March 2025
IVVD (3.74%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
27 March 2025
IVVD (3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
27 March 2025
IVVD (3.74%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
20 March 2025
IVVD (3.74%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.166533.23353293410.5010.670.475118781190.57904356CS
40.067511.250.60.67690.4615886830.54947558CS
120.284874.41860465120.38272.740.3546159732351.3031647CS
26-0.3525-34.55882352941.022.740.354680948381.25142919CS
52-1.6725-71.47435897442.342.740.354642262461.25784818CS
156-4.0325-85.79787234044.75.1950.354619520521.57878851CS
260-4.0325-85.79787234044.75.1950.354619520521.57878851CS

IVVD - Frequently Asked Questions (FAQ)

What is the current Invivyd share price?
The current share price of Invivyd is US$ 0.6675
How many Invivyd shares are in issue?
Invivyd has 119,961,445 shares in issue
What is the market cap of Invivyd?
The market capitalisation of Invivyd is USD 77.29M
What is the 1 year trading range for Invivyd share price?
Invivyd has traded in the range of US$ 0.3546 to US$ 2.74 during the past year
What is the PE ratio of Invivyd?
The price to earnings ratio of Invivyd is -3.28
What is the cash to sales ratio of Invivyd?
The cash to sales ratio of Invivyd is 21.93
What is the reporting currency for Invivyd?
Invivyd reports financial results in USD
What is the latest annual turnover for Invivyd?
The latest annual turnover of Invivyd is USD 25.38M
What is the latest annual profit for Invivyd?
The latest annual profit of Invivyd is USD -169.93M
What is the registered address of Invivyd?
The registered address for Invivyd is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Invivyd website address?
The website address for Invivyd is invivyd.com
Which industry sector does Invivyd operate in?
Invivyd operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TOIIWOncology Institute Inc
US$ 0.1698
(171.63%)
323.85k
OMEXOdyssey Marine Exploration Inc
US$ 0.860999
(102.16%)
287.46M
CEPCantor Equity Partners Inc
US$ 25.00
(51.52%)
53.71M
TMCTMC the Metals Company Inc
US$ 3.69
(44.71%)
65.61M
STROSutro Biopharma Inc
US$ 1.30
(44.44%)
4.66M
GNLNGreenlane Holdings Inc
US$ 0.015
(-93.89%)
391.59M
JZXNJiuzi Holdings Inc
US$ 2.3001
(-68.92%)
2.3M
OCEAOcean Biomedical Inc
US$ 0.0098
(-52.20%)
91.42M
INTSIntesity Therapeutics Inc
US$ 0.8799
(-32.32%)
846.2k
AGMHAGM Group Holdings Inc
US$ 0.0395
(-31.90%)
33.28M
GNLNGreenlane Holdings Inc
US$ 0.015
(-93.89%)
391.59M
DMNDamon Inc
US$ 0.0036
(-12.20%)
357.1M
OMEXOdyssey Marine Exploration Inc
US$ 0.860999
(102.16%)
287.46M
NVDANVIDIA Corporation
US$ 106.43
(3.62%)
220.81M
LRHCLa Rosa Holdings Corporation
US$ 0.1581
(29.48%)
171.65M

IVVD Discussion

View Posts
glenn1919 glenn1919 2 months ago
IVVD..........................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
👍️0
Viewmont Viewmont 2 months ago
$IVVD WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.

The presentation is set to take place at 1:20 PM ET on Wednesday, February 12th. The live webcast link will be available in the investor section of the company's website at https://investors.invivyd.com and will be archived for approximately 90 days following the event.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
👍️0
Viewmont Viewmont 2 months ago
$IVVD On February 3, 2025, the Company issued a press release entitled “Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population.” A copy of the press release is filed herewith as Exhibit 99.2 and is incorporated by reference in this Item 8.01.
👍️0
glenn1919 glenn1919 2 months ago
IVVD..........................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
IVVD......................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: L.O.L.!!! (That must be TRUMP's ass --- and the backside of his 'MAGNA' hat!!!)
👍️0
B RY B RY 3 months ago
Here's a nice fluffy pillow similar to other companies pr's, lol.>>>

👍️0
B RY B RY 3 months ago
Very true! I'll take an ivvd fda phase 3 talks with an 8k showing stronger financial strength over the fluff pr's other companies put out anyday.

👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: Very-well-stated, Dude!! (And yet every day we see yet another bogus, Pre-Clinical, study in useless Petri Dishes, Test Tubes, or in the ass of MICE!! And worse yet of late, mere "DIGITAL STUDIES" in a cheap Apple Laptop COMPUTER!!!)
👍️0
B RY B RY 3 months ago
Shorting ivvd currently is financial roulette imo.
👍️0
B RY B RY 3 months ago
I like their product being in phase 3 discussions with the fda. Phase 1 means a company is lucky to hear back from the fda. Phase 2 means the product is worth the fda's time to open discussion. Phase 3 means the fda is in serious talks about approving the product and in deep discussion with the company. Phase 4 is the final fda approval process discussions covering any unanswered fda questions and closing dialogue. That being said, I love seeing ivvd in phase 3 talks. Upon fda approval, this company should show profitable within a year or so from where it is now financially. The "emergency use" status will be a mute point with it's product fda approved for sale. I'm looking forward to seeing it's financial position in a couple of years. We have a real winner imo Invest.
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: This thing had soared HUGELY in just 3-days --- nearly 600%. But now, it's pure guess work. (EVERY company everywhere is now suddenly touting their 'revolutionary', disruptive, all-new, QUANTUM-AI-CUSTOM-TAILORED-HEALTHCARE, routines.)
👍️0
Stockexpertpro Stockexpertpro 3 months ago
GSIW 1$ Breakout Coming Shorts will have to Buy to Cover
👍️0
B RY B RY 3 months ago
I would love to sell my ivvd and buy below $2, but I seriously doubt it will retrace below $2 for more than a couple of pennies. The upcoming march 28th annual report will be too highly anticipated after monday's 8k. This ivvd ride will most certainly be the most stock fun I've had in a while. I prefer downhill skiing for a good rush, but I think as far as stocks are concerned, ivvd will prove to have a good rush as well. It's 12 month $7.89 price target will come much sooner imo. I still think testing politicians first is a good idea.
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: Indeed; and Trump already had to do that in his FIRST term, behind getting that first Covid-19 vaccine launched.
👍️0
B RY B RY 3 months ago
"Emergency use Authorization" will prove a huge asset.
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: I think Trump, Vance, & Musk, et al., are somehow cleverly-affiliated with this Firm --- especially in light of Trump's recent public digressions about how Quantum-AI-Tech will very soon be able to create TAILOR-MADE therapeutics, vaccines, treatments, inter alia, for any INDIVIDUAL patient suffering from all manner of Human afflictions; which is precisely what the IVVD company is attempting to do.
👍️0
B RY B RY 3 months ago
The strong buying since feb 3rd's "Results of Operations and Financial Conditions" 8k is in 7 weeks(mar 27th/28th) the 2024 10K will reveal the details from monday's much improved financial outlook. It will be highly anticipated reading and good reason for strong price increases leading up to it and beyond. This company much needed the turn around it's experiencing that took years in the making. Good luck to your long investments aside from the fun we have day trading most stocks. I think I'll unload a couple of my other long holds that are currently dormant. Ivvd has much more promise.

👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: I will be surprised if there is NOT yet another PR from this Firm today, on any subject.
👍️0
Zardiw Zardiw 3 months ago
#DDAmanda Video: $IVVD: Gain: +204% #1 Early Alert Stock Finder



Z
👍️0
glenn1919 glenn1919 3 months ago
IVVD..........................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
👍️0
green maschine green maschine 3 months ago
CHA-CHING💰️😁
👍️ 1
tw0122 tw0122 3 months ago
$IVVD $3.04 flip time cash out $$$I want to thank Jim Harbaugh and the NFL for pumping some more .. This broadcast is copyrighted by NFL Productions for the private use of our audience."
👍 1
TrendTrade2016 TrendTrade2016 3 months ago
3 BUCKS COMING
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
IVVD LOKKS LIKE 3 BUCKS COMING
👍 1
Invest-in-America Invest-in-America 3 months ago
IVVD: Up nearly 500% in past 5-days!! (And at TOP of following important list of all Wall Street stocks UNDER $5.00!!)
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
👍️0
Invest-in-America Invest-in-America 3 months ago
RFAC: Nope!! Did you grab it?? (Was it an IPO, which wasn't on MY IPO lists?)
👍️0
tw0122 tw0122 3 months ago
Did you see RFAC RFACU finally rolled out at 1205pm 
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: I had seen that, a few hours ago. Indeed, it's NOT "The Common Cold'!!!

I recall when the (late) Rush Limbago --- life-long pal of another Right-Wing-MORON, namely, Mark R. Levin --- proclaimed a few years ago on his reprobate AM Radio show, that Covid-19 was merely, "THE COMMON COLD, IT REALLY IS!!" (Verbatim)

And then, old Rush Limbago suddenly CROAKED via the perennial Human affliction, the "COMMON NECK CANCER", as it were --- vis-a-vis his 30-years of suckin' on CIGARS!!! (Talk about "KARMIC JUSTICE"!!!) And I wonder what ELSE the late RUSH LIMBAGO was 'suckin'-on' when flyin' up in DONALD DUMBFUCK's private jet, & Air-Force-1 during Trump's first term??????

Lastly, when TRUMP, VANCE, et al., are very soon SHOT-DOWN in Trump's AIR-FORCE-2(?), I'm gonna PARTY like it's 2099!!! (Can Prince's SON please write a song about that???!!!)
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: It's a SOLID play, Dude.
👍️0
tw0122 tw0122 3 months ago
IVVD partners with Jim Harbuagh $1.76 moving a little more 
👍️0
B RY B RY 3 months ago
Missed buying ivvd monday when I saw it around .60. No big deal. I researched it well first and bought in yesterday a little above $1 on several purchases gladly. It's now on my short and rare long hold list. Good luck Invest! I think ivvd will surpass my other long holds. A phase 3 headed for possible fda approval product, headed towards strongly possible profitability in the next 2 years, 56% inst owned. Wonderful outlook. Could hit price target much sooner imo.

👍️0
al dean al dean 3 months ago
I bought a few more on the dip. This just spiked at $1.31 again and if lot of sellers are gone, MMs forced to let it go up more. Good luck !
👍️0
TJG TJG 3 months ago
Some pre market profit taking... see how it holds up at 8 am when Pre Market goes into full trading mode
👍️0
B RY B RY 3 months ago
Interesting!>>>

👍️0
TJG TJG 3 months ago
Steady climb, Morgan Stanley has it rated at Overweight, Tipranks has it as a Moderate buy and the PR on the Phase 1/2 is nothing but solid results..Volume is double the 10 day average according to the numbers on E*Trade Snapshoot of the stock. Throw in this mornings the PR which boasted this as its headline.

DJ Invivyd Price Target Maintained With a $10.00/Share by HC Wainwright

Good enough for me to have jumped in this morning... The gap up this AM was a big excessive and is the only thing holding it back from closing at the HOD... if it can hold the mid to upper $1.20's then tomorrow it should get much closer to that $2.00 price tag.
👍️ 1
81vette 81vette 3 months ago
In .448 ,out 1.25,on to my new play
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD; (Almost) nothing can stop this puppy --- POSITIVE PR's, & articles, & price predictions every day here --- despite its not-so-tiny FLOAT. (But they might dump-more-shares-to-market at any moment, especially day-2 here into their huge run-up; that's always the BIG worry; but since IVVD already has a big FLOAT, it is very unlikely that they would DILUTE more; in truth, it's those LOW-FLOAT stocks which love to DILUTE when epic news has just sent their pre-existing FLOAT soaring.)
👍️ 1
al dean al dean 3 months ago
This thing has a good recipe going now. IVVD has an old support of $2.50. I'm thinking it is reachable. Thoughts ?
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: $2.00+ today, EEEEEE--ZZZZZZZZZZZZZZZ as PIE!!!
👍️0
glenn1919 glenn1919 3 months ago
IVVD.............................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
👍️0
weedtrader420 weedtrader420 3 months ago
IVVD ☝️🤑☝️
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: Nice day --- out, & done, for nice bank!! (But this would very well hit at least $1.50 in the Post-M today.)
👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: Slap-that-ASK --- and call it DAPHNE!!!!

👍️0
Invest-in-America Invest-in-America 3 months ago
IVVD: THANK YOU, GEEEEEEEE-ZEUS J. KRISTOOOOOOO!!!

👍 1 🥵 1 🫨 1
Invest-in-America Invest-in-America 3 months ago
IVVD: They had two good PR's today. And despite their large Float, this could still run-up nicely later; and it's at an attractive bargain price right now, anyway ya look at this cute little puppy. (Unfortunately, I grabbed this early today at $0.67, but still holding all. Hopefully, it hits circa $2.00 later today; that's ME, below, prayin' hard right now for some 'GODLY' intervention?? But, since I'm an ATHEIST, I never get much action in that regard, so to speak.)
https://www.manilatimes.net/2025/02/03/tmt-newswire/globenewswire/invivyd-announces-preliminary-fourth-quarter-2024-financial-results-strong-revenue-growth-and-reiterates-goal-of-near-term-profitability/2048771
https://finance.yahoo.com/news/invivyd-announces-positive-phase-1-120000411.html

👍️0
81vette 81vette 3 months ago
Shares to borrow nearing zero,this could explode
👍️ 1 🚀 1
green maschine green maschine 3 months ago
Price target $3.55 - $10
https://finance.yahoo.com/news/invivyd-announces-positive-phase-1-120000411.html
👍️0
green maschine green maschine 3 months ago
https://www.manilatimes.net/2025/02/03/tmt-newswire/globenewswire/invivyd-announces-preliminary-fourth-quarter-2024-financial-results-strong-revenue-growth-and-reiterates-goal-of-near-term-profitability/2048771
👍️0
green maschine green maschine 3 months ago
In @ .45
👍️0

Your Recent History

NASDAQ
IVVD
Invivyd
NASDAQI
DWHC
Dorsey Wright Healthcare...
CSE
ICP
IC Potash
NASDAQ
CBPYX
Ci Canadian Balanced Cor...
BIT
NSCIT000A250
Reconstruction Credit In...
BIT
NSCIT0540814
Archimede Investments
BIT
NSCIT1429033
CEB Council of Europe De...
BIT
NSCITA2SCAL9
European Financial Stabi...
BIT
NSCIT0004530
Deutsche Boerse
BIT
NSCIT3904009
Enel
BIT
NSCIT0013259
Republic of France
BIT
NSCIT000A326
Austria
BIT
NSCIT000A2V8
Austrian
BIT
NSCIT2491180
A2A
BIT
NSCIT1621761
International Financial
BIT
NSCIT6756430
Carraro Finance
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads